HARROW, INC. (HROW) reporting calendar
HARROW, INC. files periodic reports with the SEC as HROW on Nasdaq. Atlas tracks 73 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 17 Jul 2026 – 3 Sep 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 11 May 2026
- Reports on record
- 73
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 41 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open HROW market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 11 May 2026 | 41 days | 0001493152-26-022254 |
| 10-K | 31 Dec 2025 | 2 Mar 2026 | 61 days | 0001493152-26-008562 |
| 10-Q | 30 Sep 2025 | 10 Nov 2025 | 41 days | 0001493152-25-021562 |
| 10-Q | 30 Jun 2025 | 11 Aug 2025 | 42 days | 0001641172-25-022980 |
| 10-Q | 31 Mar 2025 | 8 May 2025 | 38 days | 0001641172-25-009263 |
| 10-K | 31 Dec 2024 | 27 Mar 2025 | 86 days | 0001641172-25-000925 |
| 10-Q | 30 Sep 2024 | 14 Nov 2024 | 45 days | 0001493152-24-045295 |
| 10-Q | 30 Jun 2024 | 7 Aug 2024 | 38 days | 0001493152-24-030575 |
| 10-Q | 31 Mar 2024 | 13 May 2024 | 43 days | 0001493152-24-018902 |
| 10-K | 31 Dec 2023 | 19 Mar 2024 | 79 days | 0001493152-24-010518 |
| 10-Q | 30 Sep 2023 | 13 Nov 2023 | 44 days | 0001493152-23-040563 |
| 10-Q | 30 Jun 2023 | 9 Aug 2023 | 40 days | 0001493152-23-027361 |
| 10-Q | 31 Mar 2023 | 11 May 2023 | 41 days | 0001493152-23-016414 |
| 10-K | 31 Dec 2022 | 23 Mar 2023 | 82 days | 0001493152-23-008718 |
| 10-Q | 30 Sep 2022 | 14 Nov 2022 | 45 days | 0001493152-22-032076 |
| 10-Q | 30 Jun 2022 | 9 Aug 2022 | 40 days | 0001493152-22-021769 |
| 10-Q | 31 Mar 2022 | 5 May 2022 | 35 days | 0001493152-22-012261 |
| 10-K | 31 Dec 2021 | 10 Mar 2022 | 69 days | 0001493152-22-006525 |
| 10-Q | 30 Sep 2021 | 9 Nov 2021 | 40 days | 0001493152-21-027697 |
| 10-Q | 30 Jun 2021 | 10 Aug 2021 | 41 days | 0001493152-21-019181 |
| 10-Q | 31 Mar 2021 | 11 May 2021 | 41 days | 0001493152-21-011033 |
| 10-K | 31 Dec 2020 | 8 Mar 2021 | 67 days | 0001493152-21-005583 |
| 10-Q | 30 Sep 2020 | 9 Nov 2020 | 40 days | 0001493152-20-020827 |
| 10-Q | 30 Jun 2020 | 10 Aug 2020 | 41 days | 0001493152-20-015093 |
| 10-Q | 31 Mar 2020 | 11 May 2020 | 41 days | 0001493152-20-008249 |
| 10-K | 31 Dec 2019 | 13 Mar 2020 | 73 days | 0001493152-20-003862 |
| 10-Q | 30 Sep 2019 | 13 Nov 2019 | 44 days | 0001493152-19-017043 |
| 10-Q | 30 Jun 2019 | 14 Aug 2019 | 45 days | 0001493152-19-012535 |
| 10-Q | 31 Mar 2019 | 9 May 2019 | 39 days | 0001493152-19-006689 |
| 10-K | 31 Dec 2018 | 12 Mar 2019 | 71 days | 0001493152-19-003188 |
| 10-Q | 30 Sep 2018 | 13 Nov 2018 | 44 days | 0001493152-18-015757 |
| 10-Q | 30 Jun 2018 | 6 Aug 2018 | 37 days | 0001493152-18-011011 |
| 10-Q | 31 Mar 2018 | 15 May 2018 | 45 days | 0001493152-18-007073 |
| 10-K | 31 Dec 2017 | 8 Mar 2018 | 67 days | 0001493152-18-003095 |
| 10-Q | 30 Sep 2017 | 14 Nov 2017 | 45 days | 0001493152-17-013187 |
| 10-Q | 30 Jun 2017 | 10 Aug 2017 | 41 days | 0001493152-17-008881 |
| 10-Q | 31 Mar 2017 | 10 May 2017 | 40 days | 0001493152-17-004968 |
| 10-K | 31 Dec 2016 | 21 Mar 2017 | 80 days | 0001493152-17-002687 |
| 10-Q | 30 Sep 2016 | 14 Nov 2016 | 45 days | 0001493152-16-014931 |
| 10-Q | 30 Jun 2016 | 15 Aug 2016 | 46 days | 0001493152-16-012435 |
Source: SEC EDGAR company submissions for CIK 0001360214. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.